Arkolith/Insider Trading/GALT/Form 4

Jamil Khurram

Chief Medical OfficerGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Jun 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$24K
Net Open-Market Flow
-$24K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2026Option exercise(M)8K$1.23$9K8K
Jun 23, 2026Sell(S)8K$3.14$24K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 23, 2026Option exercise(M)8K—$033K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000057) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML